Medical experts in Australasia have raised concern about the rising burden of severe acute pancreatitis (SAP) in intensive care units, with no change in mortality rates in these critically ill patients in almost two decades. In the absence of a speci
Pancreatitis cases keep on ICUs miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care u
Photo: Getty Images
A fresh approach to improve COVID-19 and treatment for other lung disease and innovative research on rheumatoid arthritis and cancer therapy are three areas of Flinders University research to receive a funding boost this week.
Associate Professor Jillian Carr, with Flinders colleagues, critical care medicine and respiratory physiology researchers Associate Professors Shailesh Bihari and Dani-Louise Dixon, will lead a project entitled ‘Modulating COVID-19 disease by targeting virus and virus-induced responses through pharmaceutical and mechanical ventilation strategies: SARS-CoV-2 S-protein, ACE2 and TMPRSS2’ assisted by $628,856 (APP2003683).
“With the unprecedented devastation of COVID-19, this new study will strive to find better treatments and systems to manage lung disease, and improve patient survival and recovery,” says chief investigator Associate Professor Carr.